At Pfizer Oncology, our mission is to "Outdo Cancer" by developing transformative therapies that make a meaningful impact for patients. Pfizer Oncology currently boasts an industry-leading portfolio spanning genitourinary (GU) cancers—including bladder and prostate—as well as breast, hematology-oncology, gastrointestinal-oncology, and thoracic cancers. The US Prostate Cancer business is one of the largest and fastest-growing segments within Pfizer, anchored by a multibillion-dollar portfolio that includes XTANDI, ORGOVYX, and TALZENNA. Building on this strong foundation, the team is now preparing for the anticipated launch of Mevrometostat. Mevrometostat is an innovative therapy in late-stage development, currently being evaluated in combination with enzalutamide for the treatment of metastatic Castration-Resistant Prostate Cancer (mCRPC) and metastatic Castration-Sensitive Prostate Cancer (mCSPC). This launch represents a pivotal opportunity to further expand our leadership in Prostate Cancer. This role will be responsible for ensuring launch readiness and driving a successful market introduction by leading, supporting and executing key HCP promotional efforts for the Mevrometostat US launch. Close collaboration with Global Marketing and US cross-functional partners will be essential for executing the US go-to-market launch strategy. This position requires strong HCP marketing experience, strategic and analytical thinking, creativity, solid decision-making, and a proven ability to thrive in a fast‑paced, team‑based environment with multiple competing priorities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director